中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
Allosteric Regulation of Hsp90 alpha's Activity by Small Molecules Targeting the Middle Domain of the Chaperone

文献类型：期刊论文

作者Zhou, Chen1; Zhang, Chi2; Zhu, Hongwen1,2; Liu, Zhijun3; Su, Haixia2,4; Zhang, Xianglei2,4; Chen, Tingting2,4; Zhong, Yan1,4; Hu, Huifang1,4; Xiong, Muya2,4
刊名ISCIENCE
出版日期2020-02-21
卷号23期号:2页码:46
DOI10.1016/j.isci.2020.100857
通讯作者Xu, Yechun(ycxu@simm.ac.cn) ; Zhang, Ao(aozhang@simm.ac.cn) ; Zhang, Naixia(nxzhang@simmn.ac.cn)
英文摘要Hsp90 is a target for anti-cancer drug development. Both the conformational events tuned by ATP/ADP and co-chaperones and the chaperoning cycle timing are required for Hsp90's fully functional display. Interfering with either one of the conformational events or the cycle timing will down-regulate Hsp90's function. In this manuscript, non-covalent allosteric modulators (SOMCL-16-171 and SOMCL-16-175) targeting Hsp90 alpha's middle domain (Hsp90M) were developed for the first time. Multiple techniques were then applied to characterize the interactions between two active compounds and lisp90 alpha. Two loops and one alpha-helix (F349-N360, K443-E451, and D372-G387) in Hsp90M were identified responsible for the recognition of SOMCL-16-171 and SOMCL-16-175. Meanwhile, the binding of SOMCL-16-171 and SOMCL-16-175 to Hsp90M was demonstrated to allosterically modulate the structure and function of Hsp90's N-terminal domain. Finally, cellular assays were conducted to evaluate the cellular activity of SOMCL-16-175, and the results indicate that SOMCL-16-175 destabilizes Hsp90's client proteins and reduces cell viability.
WOS关键词N-TERMINAL DOMAIN ; CLIENT PROTEIN ; ATPASE ACTIVITY ; HSP90 ; ACTIVATION ; CYCLE ; DEGRADATION ; INHIBITION ; ASSIGNMENT ; MECHANISM
资助项目National Natural Science Foundation of China[21778061] ; National Natural Science Foundation of China[81430080] ; National Natural Science Foundation of China[21977105] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002]
WOS研究方向Science & Technology - Other Topics
语种英语
WOS记录号WOS:000518637100004
出版者CELL PRESS
源URL[http://119.78.100.183/handle/2S10ELR8/281023]  
专题中国科学院上海药物研究所
通讯作者Xu, Yechun; Zhang, Ao; Zhang, Naixia
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Natl Facil Prot Sci Shanghai, Shanghai Adv Res Inst, ZhangJiang Lab, Shanghai 201210, Peoples R China
4.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714		 Zhou, Chen,Zhang, Chi,Zhu, Hongwen,et al. Allosteric Regulation of Hsp90 alpha's Activity by Small Molecules Targeting the Middle Domain of the Chaperone[J]. ISCIENCE,2020,23(2):46.
APA Zhou, Chen.,Zhang, Chi.,Zhu, Hongwen.,Liu, Zhijun.,Su, Haixia.,...&Zhang, Naixia.(2020).Allosteric Regulation of Hsp90 alpha's Activity by Small Molecules Targeting the Middle Domain of the Chaperone.ISCIENCE,23(2),46.
MLA Zhou, Chen,et al."Allosteric Regulation of Hsp90 alpha's Activity by Small Molecules Targeting the Middle Domain of the Chaperone".ISCIENCE 23.2(2020):46.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。